Competitive problems in the drug industry 1 edition
Competitive problems in the drug industry
hearings before Subcommittee on Monopoly and Anticompetitive Activities of the Select Committee on Small Business, United States Senate, Ninetieth Congress, first session ...
U.S. Govt. Print. Off.
Written in English.
Table of Contents
|pt. 28. Oral hypoglycemic drugs.|
|pt. 29. Government procurement (vol. 8), (Bioequivalence and bioavailability).|
|v. 30.Pharmaceutical industry and medical education (vol. 1).|
|pt. 31. Safety and efficacy of anti-obesity drugs.|
|pt. 32. Pharmaceutical company practices in labeling and promoting prescription drugs sold in Latin America.|
|pt. 33 Drug quality, competition, and government procurement of drugs.|
|Pt. 34. Hearings before the Select Committee on Small Business, Jan. 31, Feb. 1 and 5, 1979.|
Hearings held May 15, 1967-
Pts. 1-32 of these hearings held before the subcommittee under its earlier name: Subcommittee on Monopoly.
Oral hypoglycemic drugs.
Includes bibliographical references.
|Drug quality, competition, and government procurement of drugs., Safety, efficacy, and usefulness of Darvon and other prparations containing propoxyphene.|
The Physical Object